日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia

PCSK9抑制剂治疗COVID-19:增强干扰素在伴有高胆固醇血症患者中的抗病毒作用的机会

Vuorio, A; Kovanen, P T

Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells

细胞内RNA识别通路激活人肥大细胞中强烈的抗病毒反应

Lappalainen, J; Rintahaka, J; Kovanen, P T; Matikainen, S; Eklund, K K

Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.

甲磺酸伊马替尼抑制 c-kit 酪氨酸激酶可诱导类风湿性滑膜肥大细胞凋亡:一种治疗关节炎的潜在方法

Juurikivi A, Sandler C, Lindstedt K A, Kovanen P T, Juutilainen T, Leskinen M J, Mäki T, Eklund K K

Changes in a phospholipid bilayer induced by the hydrolysis of a phospholipase A2 enzyme: a molecular dynamics simulation study

磷脂酶A2酶水解诱导磷脂双层膜变化:分子动力学模拟研究

Hyvönen, M T; Oörni, K; Kovanen, P T; Ala-Korpela, M

Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?

人体心脏中血管紧张素II的形成:是通过ACE介导的途径还是非ACE介导的途径?

Kokkonen, J O; Saarinen, J; Kovanen, P T

The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland

低密度脂蛋白受体基因的北卡累利阿家族性高胆固醇血症(FH)突变会缺失第6外显子的7个核苷酸,是芬兰FH的常见病因。

Koivisto, U M; Turtola, H; Aalto-Setälä, K; Top, B; Frants, R R; Kovanen, P T; Syvänen, A C; Kontula, K